BioNexus KC celebrates ‘regional backbone’ connecting science, talent, tech and momentum
The scale of opportunities within Kansas City’s bio health industry would’ve been challenging to imagine even just five years ago, said Dennis Ridenour, touting a streak of groundbreakings, collaborations, game-changing announcements, and major investments — all rallying together the right people and institutions. Dennis Ridenour, president and CEO of BioNexus KC in Kansas City, celebrated the region's'regional backbone' connecting science, talent, tech and momentum. He highlighted successes within the bio health industry, including a $1 million grant from the Patterson Family Foundation to advance rural health, $38.1 billion in federal and local funding through the Tech Hubs Initiative for biologics and next-generation medicines, and a partnership with Rare KC, an organization dedicated to supporting individuals and families with rare disease. Dr. Douglas Girod, chancellor for the University of Kansas, emphasized the need for greater collaboration as research funding is changing. Dr Allyson Berent, a veterinarian, scientist, and leader in rare disease drug development, was keynote speaker at the BioNEXus KC event.
Opublikowany : 2 dni temu za pomocą Tommy Felts w Health Tech Science
The scale of opportunities within Kansas City’s bio health industry would’ve been challenging to imagine even just five years ago, said Dennis Ridenour, touting a streak of groundbreakings, collaborat... [5440 symbols]
